Gastroenterology Practice Questions

Q: Which one of the following is not a sequela of pancreatitis?

Hypercalcemia. In acute pancreatitis, the biochemical hallmark is **hypocalcemia**, not hypercalcemia. Therefore, Option D is the correct answer as it is not a sequela of the condition. ### **Explanation of Options** * **Hypercalcemia (Correct Answer):** Hypocalcemia occurs in severe pancreatitis due to **saponification**—the deposition of calcium soaps in areas of fat necrosis. Additionally, a transient hypoparathyroidism or hypoalbuminemia may contribute. Note: While hypercalcemia is a *cause* of pancreatitis (via activation of trypsinogen), it is not a *sequela* (consequence). * **Hyperbilirubinemia:** This occurs in approximately 10–20% of patients. It is usually due to compression of the intrapancreatic portion of the common bile duct by inflammatory edema or a pancreatic pseudocyst [1]. * **Increased Hematocrit:** This is a sign of **hemoconcentration** resulting from significant third-space fluid loss into the retroperitoneum and peritoneal cavity [1]. A hematocrit >44% on admission is a strong predictor of pancreatic necrosis. * **Hyperglycemia:** This is common and multifactorial, resulting from decreased insulin release (islet cell damage), increased glucagon release, and the systemic stress response (increased catecholamines and cortisol). ### **Clinical Pearls for NEET-PG** * **Ranson’s Criteria:** Remember that a fall in hematocrit (>10%) and a fall in serum calcium (<8 mg/dL) within 48 hours are indicators of poor prognosis [1]. * **Grey Turner’s Sign:** Ecchymosis of the flanks, indicating retroperitoneal hemorrhage. * **Cullen’s Sign:** Periumbilical ecchymosis. * **Most Common Cause:** Gallstones (overall), followed by Alcohol. * **Drug-induced Pancreatitis:** Common culprits include Azathioprine, Sulfonamides, Valproate, and Thiazides.

Q: A businessman diagnosed with gastroesophageal reflux disease (GERD) presents with substernal heartburn. What is the best test to diagnose GERD and quantify acid output?

24-hour pH monitoring. **Explanation:** The diagnosis of Gastroesophageal Reflux Disease (GERD) is primarily clinical; however, when objective confirmation and quantification of acid exposure are required, **24-hour ambulatory pH monitoring** is the **Gold Standard**. It allows for the correlation of symptoms (heartburn, cough) with actual reflux episodes by measuring the percentage of time the esophageal pH remains below 4.0. **Analysis of Options:** * **24-hour pH monitoring (Correct):** It is the most sensitive and specific test to diagnose GERD and is the only modality that can **quantify** the total acid output/exposure over a day. * **Endoscopy (EGD):** While it is the first-line investigation to look for complications (like Barrett’s esophagus or esophagitis), it has low sensitivity for diagnosing GERD itself, as many patients have "Non-Erosive Reflux Disease" (NERD) where the mucosa appears normal. * **Manometry:** This is used to assess esophageal motility (e.g., Achalasia) and to locate the Lower Esophageal Sphincter (LES) before pH probe placement or anti-reflux surgery. It does not diagnose or quantify acid reflux. * **Esophagogram (Barium Swallow):** This is useful for identifying structural abnormalities like hiatal hernias, strictures, or rings, but it cannot reliably diagnose or quantify GERD. **Clinical Pearls for NEET-PG:** * **Investigation of Choice (IOC) for GERD:** 24-hour pH monitoring. * **Best Initial Investigation:** Upper GI Endoscopy (to rule out malignancy/complications). * **DeMeester Score:** A composite score used in pH monitoring to quantify the severity of reflux (Score >14.72 indicates significant GERD). * **Bravo Capsule:** A wireless pH monitoring system that is better tolerated than the transnasal catheter.

Q: Which of the following is not associated with Crohn's disease?

None. **Explanation:** The correct answer is **None**, as all the listed options (Fistula, Stricture, and Sclerosing Cholangitis) are well-recognized associations or complications of Crohn’s Disease (CD). 1. **Fistula (Option A):** Crohn’s disease is characterized by **transmural inflammation** (involving all layers of the bowel wall). This deep inflammation leads to the formation of sinus tracts that can penetrate through the serosa into adjacent organs or the skin, resulting in entero-enteric, entero-vesical, or perianal fistulae. 2. **Stricture (Option B):** Chronic transmural inflammation leads to collagen deposition and fibrosis. Over time, this causes narrowing of the bowel lumen, resulting in fibrostenotic strictures, a hallmark feature of CD that often leads to intestinal obstruction [1]. 3. **Sclerosing Cholangitis (Option C):** Primary Sclerosing Cholangitis (PSC) is an extra-intestinal manifestation of Inflammatory Bowel Disease (IBD). While PSC is more strongly associated with Ulcerative Colitis (approx. 70-80% of PSC patients have UC), it is also significantly associated with Crohn’s disease, particularly when there is colonic involvement [1]. **NEET-PG High-Yield Pearls:** * **Transmural vs. Mucosal:** CD is transmural (leads to fistulae/strictures); UC is limited to the mucosa/submucosa (leads to pseudopolyps). * **Skip Lesions:** CD presents with "skip lesions" and a "cobblestone appearance," whereas UC involves continuous inflammation starting from the rectum. * **Granulomas:** Non-caseating granulomas are pathognomonic for CD (found in ~40-60% of cases) but are absent in UC. * **Smoking:** Smoking is a risk factor for CD but appears to be protective against UC.

Q: In portal hypertension, what are the sites of portosystemic anastomosis?

All of the above. Explanation: Portal hypertension occurs when the pressure in the portal venous system increases, leading to the opening of collateral channels between the portal and systemic venous systems [1]. These sites of **portosystemic anastomosis** are critical clinical landmarks. **1. Lower end of esophagus (Option A):** Here, the **left gastric vein** (portal) anastomoses with the **azygos vein** (systemic). Clinically, this manifests as **esophageal varices**, which are prone to life-threatening hematemesis [1]. **2. Around the umbilicus (Option B):** The **paraumbilical veins** (portal) communicate with the **superficial epigastric veins** (systemic). Dilatation of these veins results in the classic **"Caput Medusae"** appearance [1]. **3. Lower third of the rectum and anal canal (Option C):** The **superior rectal vein** (portal) anastomoses with the **middle and inferior rectal veins** (systemic). This leads to the formation of **anorectal varices** (distinct from internal hemorrhoids) [1]. **Conclusion:** Since all three sites represent major areas where the portal and systemic circulations meet, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Retroperitoneal (Retzius) Site:** Anastomosis between colic veins (portal) and renal/lumbar veins (systemic) [1]. * **Bare area of the liver:** Anastomosis between hepatic portal veins and phrenic veins (systemic). * **Cruveilhier-Baumgarten Syndrome:** A clinical sign where a venous hum is heard over the epigastrium due to recanalization of the umbilical vein. * **Most common site of bleeding:** Esophageal varices.

Q: Which test is used to diagnose pancreatic steatorrhea?

Fecal elastase level. ### Explanation **Correct Option: D. Fecal elastase level** Pancreatic steatorrhea occurs when the pancreas fails to produce or secrete sufficient digestive enzymes (Exocrine Pancreatic Insufficiency - EPI), leading to malabsorption of fats. **Fecal Elastase-1** is a proteolytic enzyme produced by the pancreas that remains stable during intestinal transit and is concentrated in the stool [1]. * **Mechanism:** Because it is not degraded by other enzymes, its concentration in feces directly reflects pancreatic exocrine secretory capacity [1]. * **Clinical Significance:** A level **<200 µg/g** of stool is diagnostic of EPI. It is the preferred non-invasive "gold standard" screening test due to its high sensitivity and specificity compared to other stool tests. **Why other options are incorrect:** * **A. Schilling test:** Historically used to determine the cause of Vitamin B12 deficiency (e.g., Pernicious anemia vs. malabsorption). It does not measure fat malabsorption. * **B & C. Serum Lipase and Amylase:** These are markers of **acute pancreatic inflammation** (Acute Pancreatitis). In chronic pancreatic insufficiency leading to steatorrhea, these levels are typically normal or even low due to the destruction of acinar tissue. **NEET-PG High-Yield Pearls:** * **Definition of Steatorrhea:** Excretion of **>7g of fat/day** in stool (on a 100g fat diet). * **72-hour Fecal Fat Estimation:** The definitive quantitative test for steatorrhea, but clinically cumbersome compared to fecal elastase. * **Sudan III Stain:** A rapid qualitative screening test for fecal fat. * **Secretin Stimulation Test:** The most sensitive **invasive** test for early chronic pancreatitis, but rarely performed due to its complexity. * **Clinical Rule:** Steatorrhea usually only manifests when **>90%** of pancreatic exocrine function is lost.

Q: A patient presents with unconjugated hyperbilirubinemia and elevated urobilinogen levels in urine. What is the most likely diagnosis?

Hemolytic Jaundice. The clinical presentation of **unconjugated hyperbilirubinemia** combined with **elevated urinary urobilinogen** is a classic hallmark of **Hemolytic Jaundice**. [1] **1. Why Hemolytic Jaundice is correct:** In hemolysis, there is an excessive breakdown of hemoglobin, leading to an overproduction of unconjugated bilirubin (UCB). The liver conjugates as much as possible and excretes it into the bile. In the intestine, this excess bilirubin is converted by bacteria into **stercobilinogen/urobilinogen**. A significant portion of this increased urobilinogen is reabsorbed into the portal circulation (enterohepatic circulation) and subsequently excreted by the kidneys, leading to high urinary urobilinogen levels. [1] Notably, urine bilirubin is absent (acholuric jaundice) because UCB is water-insoluble. **2. Why other options are incorrect:** * **Gilbert’s & Crigler-Najjar Syndromes:** These are genetic defects in the conjugation enzyme (UGT1A1). [1] While they cause unconjugated hyperbilirubinemia, the total amount of bilirubin reaching the gut is **decreased or normal**, meaning urobilinogen levels will not be elevated. * **Dubin-Johnson Syndrome:** This is a conjugated hyperbilirubinemia caused by a defect in bilirubin excretion into the bile canaliculi. [1] It would present with bilirubinuria (dark urine) rather than isolated urobilinogen elevation. **High-Yield NEET-PG Pearls:** * **Hemolysis:** ↑ UCB, ↑ Urinary Urobilinogen, **Absent** Urinary Bilirubin. [1] * **Obstructive Jaundice:** ↑ Conjugated Bilirubin, **Absent** Urinary Urobilinogen (bile doesn't reach the gut), **Present** Urinary Bilirubin. [2] * **Gilbert Syndrome:** Most common hereditary hyperbilirubinemia; jaundice is typically triggered by fasting or stress. [1] * **Dubin-Johnson:** Characterized by a **black liver** on biopsy due to melanin-like pigment.

Q: A patient presenting with spider telangiectatic spots on the skin should undergo examination to determine the condition of which organ?

Liver. **Explanation:** Spider telangiectasias (spider angiomas) are classic cutaneous markers of **chronic liver disease (CLD)**, most commonly associated with cirrhosis [1]. **Why Liver is Correct:** The primary pathophysiology involves **hyperestrogenism**. In a failing liver, there is decreased metabolism of steroid hormones and increased peripheral conversion of androgens to estrogens [1]. Elevated circulating estrogen levels cause permanent dilatation of precapillary arterioles. These lesions typically appear in the distribution of the superior vena cava (face, neck, upper chest, and arms) and exhibit "central pulsatility" with peripheral radiating capillaries that blanch upon pressure. **Why Other Options are Incorrect:** * **Lungs:** While hepatopulmonary syndrome can occur in liver patients, spider nevi are not a direct sign of primary lung pathology. * **Kidneys:** Chronic Kidney Disease (CKD) presents with skin changes like uremic frost, pruritus, or hyperpigmentation, but not spider telangiectasias [2]. * **Pancreas:** Chronic pancreatitis or pancreatic cancer may cause jaundice (if the bile duct is obstructed) or migratory thrombophlebitis (Trousseau sign), but they do not typically cause hyperestrogenism-induced vascular changes. **High-Yield Clinical Pearls for NEET-PG:** * **Number Matters:** Finding more than **five** spider angiomas is highly suggestive of liver cirrhosis [3]. * **Other Hyperestrogenic States:** They can also be seen in pregnancy and thyrotoxicosis. * **Associated Findings:** Often seen alongside other "estrogen-excess" signs like **palmar erythema** and **gynecomastia** [1]. * **Disappearance:** These lesions often disappear if liver function improves or following a liver transplant.

Q: Which autoantibodies are seen in type 1 autoimmune hepatitis?

Anti-nuclear antibodies. **Explanation:** Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterized by hypergammaglobulinemia and the presence of specific circulating autoantibodies. It is broadly classified into two types based on the antibody profile: * **Type 1 AIH (Classic):** This is the most common form (80% of cases) and can occur at any age. It is characterized by the presence of **Anti-nuclear antibodies (ANA)** and/or **Anti-smooth muscle antibodies (ASMA)**. * **Type 2 AIH:** This type typically affects children and adolescents. It is characterized by **Anti-liver kidney microsomal type 1 (Anti-LKM-1)** antibodies and/or Anti-liver cytosol type 1 (Anti-LC1) antibodies. **Analysis of Options:** * **Option A (Anti-mitochondrial antibodies):** These are the hallmark of **Primary Biliary Cholangitis (PBC)**, not AIH. * **Option C (Anti-LKM-1 antibodies):** These are diagnostic for **Type 2 AIH**, which is clinically more severe and often resistant to treatment compared to Type 1. * **Option D (Anti-LKM-2 antibodies):** These are associated with **drug-induced hepatitis** (specifically ticrynafen), not autoimmune hepatitis. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver biopsy showing **Interface Hepatitis** (piecemeal necrosis) and plasma cell infiltration. * **Treatment:** Prednisolone (corticosteroids) alone or in combination with Azathioprine. * **Associated Conditions:** Type 1 AIH is frequently associated with other autoimmune diseases like HLA-DR3 or DR4, autoimmune thyroiditis, and Celiac disease. * **Seronegative AIH:** About 10-20% of patients may be antibody-negative at presentation.

Q: All of the following are seen in chronic calcific pancreatitis except?

Hypercalcemia. **Explanation:** Chronic calcific pancreatitis (CCP) is characterized by progressive, irreversible inflammation leading to the destruction of both endocrine and exocrine components of the pancreas [1]. **Why Hypercalcemia is the Correct Answer:** Hypercalcemia is a **cause**, not a consequence, of chronic pancreatitis. Elevated serum calcium levels (often due to primary hyperparathyroidism) can lead to the formation of intraductal calcium stones and the activation of trypsinogen within the pancreas, triggering inflammation. Conversely, chronic pancreatitis itself does not cause hypercalcemia; in fact, severe acute episodes can sometimes lead to *hypocalcemia* due to the saponification of fats [1]. **Analysis of Incorrect Options:** * **Diabetes Mellitus:** This is a late-stage complication. Destruction of the Islets of Langerhans leads to "pancreatogenic diabetes" (Type 3c DM), characterized by a loss of both insulin and glucagon. * **Fat Malabsorption:** Exocrine insufficiency occurs when >90% of the pancreatic function is lost. This results in steatorrhea (foul-smelling, oily stools) because the pancreas fails to secrete adequate lipase [1]. * **Recurrent Abdominal Pain:** This is the most common presenting symptom [1]. The pain is typically epigastric, radiates to the back, and is caused by increased intrapancreatic pressure and neural inflammation [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Triad:** Pancreatic calcification (most specific), steatorrhea, and diabetes mellitus. * **Most Common Cause:** Alcohol abuse (Western world); Tropical pancreatitis (common in parts of India) [1]. * **Imaging:** CT scan is the gold standard for detecting calcifications [2]. * **Management:** Enzyme replacement (Creon) for malabsorption and "step-up" analgesia for pain.

Question 1

Which one of the following is not a sequela of pancreatitis?

Accepted Answer

Hypercalcemia

Answer

Hyperbilirubinemia

Answer

Hematocrit increased

Answer

Hyperglycemia

Question 2

A businessman diagnosed with gastroesophageal reflux disease (GERD) presents with substernal heartburn. What is the best test to diagnose GERD and quantify acid output?

Accepted Answer

24-hour pH monitoring

Answer

Esophagogram

Answer

Endoscopy

Answer

Manometry

Question 3

Which of the following is not associated with Crohn's disease?

Accepted Answer

None

Answer

Fistula

Answer

Stricture

Answer

Sclerosing cholangitis

Question 4

In portal hypertension, what are the sites of portosystemic anastomosis?

Accepted Answer

All of the above

Answer

Lower end of esophagus

Answer

Around the umbilicus

Answer

Lower third of the rectum and anal canal

Question 5

Which test is used to diagnose pancreatic steatorrhea?

Accepted Answer

Fecal elastase level

Answer

Schilling test

Answer

Serum lipase

Answer

Serum amylase

Question 6

A patient presents with unconjugated hyperbilirubinemia and elevated urobilinogen levels in urine. What is the most likely diagnosis?

Accepted Answer

Hemolytic Jaundice

Answer

Crigler-Najjar syndrome

Answer

Gilbert's syndrome

Answer

Dubin-Johnson syndrome

Question 7

A patient presenting with spider telangiectatic spots on the skin should undergo examination to determine the condition of which organ?

Accepted Answer

Liver

Answer

Lungs

Answer

Kidneys

Answer

Pancreas

Question 8

Which autoantibodies are seen in type 1 autoimmune hepatitis?

Accepted Answer

Anti-nuclear antibodies

Answer

Anti-mitochondrial antibodies

Answer

Anti-LKM-1 antibodies

Answer

Anti-LKM-2 antibodies

Question 9

A 45-year-old male presents with fever, chronic diarrhea, and weight loss. He is found to have migratory polyarthritis and generalized lymphadenopathy. Physical examination reveals skin hyperpigmentation. A biopsy from his small intestines reveals the presence of macrophages in the lamina propria that contain PAS-positive cytoplasm. What is the most likely diagnosis for this individual?

Accepted Answer

Whipple's disease

Answer

Crohn's disease

Answer

Hanup disease

Answer

Nontropical sprue

Question 10

All of the following are seen in chronic calcific pancreatitis except?

Accepted Answer

Hypercalcemia

Answer

Diabetes mellitus

Answer

Fat malabsorption

Answer

Recurrent abdominal pain

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?